Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone, droperidol and ginger for control of postoperative nausea and vomiting in cholecystitis surgery
IRCT20230506058101N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone, droperidol and ginger in cholecystitis and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Arak University of Medical Sciences. Started Jun 2023; status: completed.
02
Drugs
dexamethasonedroperidolginger
03
Conditions
cholecystitispostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20230506058101N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230506058101N1.